Young Patients With Acute Myocardial InfarctionNCT07919925
Elicit Drugs in Myocardial Infarction
An observational study of Young Patients With Acute Myocardial Infarction, run by Sohag University.
Trial summary
Estimation of prevalence of abuse elicit drugs among young patients admitted with diagnosis of acute myocardial infarction and determination of inhospital out come and cardiovascular complications of those patients Read more about this study
- Who is it for?
- Ages Up to 44 years
- Conditions the study is for
- Young Patients With Acute Myocardial Infarction
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 5 Nov 2026to 1 Oct 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 44 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: The study population will consist of 100 consecutive young patients aged less than 45 years old , admitted to the Coronary Care Unit at Sohag University Hospital with a diagnosis of acute myocardial infarction, including both ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI).
Who may be able to join
- Young Patients with Acute Myocardial Infarction (ST-elevation-myocardial infarction *STEMI* \&Non ST-elevation-myocardial infarction*NSTEMI* )less than 45 Years Old
Who cannot join
- patients with Acute Myocardial Infarction 45 Years Old or older
- patients with other cardiac diseases like Rheumatic Heart Disease ,Congenital heart diseases,Cardiomyopathies and pericardial disease
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Study of Elicit Drugs in Young Patient With Acute Myocardial Infarction in Sohag University
Estimation of prevalence of abuse elicit drugs among young patients admitted with diagnosis of acute myocardial infarction and determination of inhospital out come and cardiovascular complications of those patients
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| An observational cohort study will be carried out on young patient <45 admitted to ccu | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of illicit drug abuse among young patients with Acute Myocardial Infarction
Measured: From hospital admission through 30 days after discharge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Nov 2026
- Study start5 Nov 2026 (estimated)
- Primary completion10 Jun 2027 (estimated)
- Study completion1 Oct 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Young Patients With Acute Myocardial InfarctionStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Hassan Ahmed Hassanien, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07919925
- Sponsor's protocol ID
- Soh-Med-26-10-1MS
- Status last verified
- Oct 2026
- First submitted
- 31 Oct 2026
- Last updated
- 5 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study of Elicit Drugs in Young Patient With Acute Myocardial Infarction in Sohag University
- ClinicalTrials.gov ID
- NCT07919925
- Acronym / sponsor ID
- Soh-Med-26-10-1MS
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 5 Nov 2026 (estimated)
- Primary completion
- 10 Jun 2027 (estimated)
- Study completion
- 1 Oct 2027 (estimated)
- First posted
- 5 Nov 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Estimation of prevalence of abuse elicit drugs among young patients admitted with diagnosis of acute myocardial infarction and determination of inhospital out come and cardiovascular complications of those patients
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| An observational cohort study will be carried out on young patient <45 admitted to ccu | – | – |
Who may qualify
- Ages
- Up to 44 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- The study population will consist of 100 consecutive young patients aged less than 45 years old , admitted to the Coronary Care Unit at Sohag University Hospital with a diagnosis of acute myocardial infarction, including both ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI).
Key inclusion criteria (1 listed)
- Young Patients with Acute Myocardial Infarction (ST-elevation-myocardial infarction *STEMI* \&Non ST-elevation-myocardial infarction*NSTEMI* )less than 45 Years Old
Key exclusion criteria (2 listed)
- patients with Acute Myocardial Infarction 45 Years Old or older
- patients with other cardiac diseases like Rheumatic Heart Disease ,Congenital heart diseases,Cardiomyopathies and pericardial disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Prevalence of illicit drug abuse among young patients with Acute Myocardial Infarction
Time frame: From hospital admission through 30 days after discharge
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Nov 2026.
- Individual participant dataSharing planned: No
Related trials for Young Patients With Acute Myocardial Infarction
Not yet recruitingObservational study
Clinical Features and Long-Term Prognosis in Young Patients With Acute Myocardial Infarction
ACS (Acute Coronary Syndrome), Young Adults
RecruitingObservational study
PRemature Acute Myocardial Infarction Register of Serbia
Acute Coronary Syndromes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Young Patients With Acute Myocardial Infarction, run by Sohag University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mohamed Hassan (0201066185992, mohamed_hassan_post@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of illicit drug abuse among young patients with Acute Myocardial Infarction (time frame: From hospital admission through 30 days after discharge). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026.